• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".

作者信息

Gonzalez Rodriguez Elena, Lamy Olivier

机构信息

Bone Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3535-3536. doi: 10.1210/jc.2019-00747.

DOI:10.1210/jc.2019-00747
PMID:30998233
Abstract
摘要

相似文献

1
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3535-3536. doi: 10.1210/jc.2019-00747.
2
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".致编辑的信：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5181-5182. doi: 10.1210/jc.2019-01017.
3
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".致编辑的信：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2020 Jan 1;105(1). doi: 10.1210/clinem/dgz131.
4
Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".对致编辑信的回复：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3537-3538. doi: 10.1210/jc.2019-00777.
5
Letter to the Editor: "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women".
J Clin Endocrinol Metab. 2019 Sep 1;104(9):3609. doi: 10.1210/jc.2019-00785.
6
Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database.英国普通实践研究数据库中绝经后妇女骨质疏松症药物的坚持情况。
Menopause. 2012 Jan;19(1):33-40. doi: 10.1097/gme.0b013e318221bacd.
7
Reply to Letter to the Editor: Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.致编辑的信的回复：罗莫单抗在患有骨质疏松症和轻至中度慢性肾脏病的绝经后女性中的疗效和安全性
J Bone Miner Res. 2023 Feb;38(2):356. doi: 10.1002/jbmr.4761. Epub 2023 Jan 25.
8
Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture.绝经后高骨折风险女性的骨质疏松症治疗
JAMA. 2016 Aug 16;316(7):715-6. doi: 10.1001/jama.2016.11032.
9
Postmenopausal osteoporosis risk management in primary care: how well does it adhere to national practice guidelines?初级保健中绝经后骨质疏松症的风险管理：其对国家实践指南的遵循程度如何？
J Am Med Womens Assoc (1972). 2003 Spring;58(2):99-104.
10
Relationship between osteoporosis and cardiovascular disease in postmenopausal women.绝经后女性骨质疏松症与心血管疾病之间的关系。
J Bone Miner Res. 2005 Nov;20(11):1912-20. doi: 10.1359/JBMR.050711. Epub 2005 Jul 18.